New developments in quantitative polymerase chain reaction applied to control the quality of heparins

Analytical and Bioanalytical Chemistry

Volumn 399, Issue 2, 2011, Pages 747-755

  Auguste, Cécile ^a   Dereux, Stéphanie ^a   Martinez, Céline ^a   Anger, Pascal ^a  

^a Process Development Biotechnology Division   (France)

Author keywords

Contamination; Heparin; PCR; Quality assurance control

Indexed keywords

ANALYTICAL METHOD; ANALYTICAL TECHNIQUES; ANIMAL SPECIES; CHONDROITIN SULFATES; COMPLEX MIXTURE; GLYCOSAMINOGLYCANS; HEPARIN; IMPURITIES IN; INTESTINAL MUCOSA; PCR; PCR METHOD; PROCESSING UNITS; QUALITY ASSURANCE/CONTROL; QUANTITATIVE POLYMERASE CHAIN REACTION; SANOFI-AVENTIS;

CONTAMINATION; DRUG PRODUCTS; IMPURITIES; POLYMERIZATION; POLYSACCHARIDES; QUALITY CONTROL;

POLYMERASE CHAIN REACTION;

ANTICOAGULANT AGENT; CHONDROITIN SULFATE; DERMATAN SULFATE; DNA; GLYCOSAMINOGLYCAN; HEPARIN; NUCLEOTIDE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG CONTAMINATION; EVALUATION; METHODOLOGY; POLYMERASE CHAIN REACTION; QUALITY CONTROL; SWINE;

ANIMALS; ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; DNA; DRUG CONTAMINATION; GLYCOSAMINOGLYCANS; HEPARIN; NUCLEOTIDES; POLYMERASE CHAIN REACTION; QUALITY CONTROL; SWINE;

ANIMALIA; SUS;

EID: 79251639043     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4232-4     Document Type: Article

References (20)

1. H Liu Z Zhang RJ Linhardt 2009 Lessons learned from the contamination of heparin Nat Prod Rep 26 3 313 321 1:CAS:528:DC%2BD1MXisVGjsL8%3D 10.1039/b819896a
2. European Directorate for the Quality of Medicines and Health Care (2010) European Pharmacopoeia Monograph PA/PH/Exp. 6/T (09) 42 PUB. http://www.edqm.eu. Accessed July 2010
3. US Pharmacopeia (2010) http://www.usp.org. Accessed July 2010
4. Japanese Pharmacopeia (2010) http://www.sjp.jp/eng. Accessed July 2010
5. DA Keire DJ Mans H Ye RE Kolinski LF Buhse 2010 Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches J Pharm Biomed Anal 52 656 664 1:CAS:528:DC%2BC3cXksVamsrs%3D 10.1016/j.jpba.2010.02.019
6. I McEwen A Amini IM Olofsson 2010 Identification and purity test of heparin by NMR. A summary of two years' experience at the medical products agency Pharmeuropa Bio & Scientific Notes 1 65 72
7. T Maruyama T Toida T Imanari G Yu RJ Linhardt 1998 Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation Carbohydr Res 306 1-2 35 43 1:CAS:528:DyaK1cXksFCit78%3D 10.1016/S0008-6215(97) 10060-X
8. R Jayakumar N Nwe S Tokura H Tamura 2007 Sulfated chitin and chitosan as novel biomaterials Int J Biol Macromol 40 175 181 1:CAS:528:DC%2BD2sXhs1Chtrc%3D 10.1016/j.ijbiomac.2006.06.021
9. PAS Mourao 2004 Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives Curr Pharm Des 10 9 967 981 1:CAS:528:DC%2BD2cXitlCjtL4%3D 10.2174/1381612043452730
10. ZM Wanga L Li KJ Xiao JY Wub 2009 Homogeneous sulfation of bagasse cellulose in an ionic liquid and anticoagulation activity Bioresour Technol 100 1687 1690 10.1016/j.biortech.2008.09.002
11. U Lindahl JP Li M Kusche-Gullberg M Salmivirta S Alaranta T Veromaa J Emeis I Roberts C Taylor P Oreste G Zoppetti A Naggi G Torri B Casu 2005 Generation of "neoheparin" from E. coli K5 capsular polysaccharide J Med Chem 48 2 349 352 1:CAS:528:DC%2BD2MXjslWi 10.1021/jm049812m
12. KV Prashantha Harish RN Tharanathan 2007 Trends Food Sci Technol 18 3 117 131 10.1016/j.tifs.2006.10.022
13. C Houiste C Auguste C Macrez S Dereux A Derouet P Anger 2009 Q-PCR and disaccharide profiling to characterize the animal origin of LMWH Clin Appl Thromb Hemost 15 1 50 58 1:CAS:528:DC%2BD1MXisFSgsL0%3D 10.1177/1076029608320831
14. Taconet L (2010) European Pharmacopoeia update. In: 4th Workshop on the characterisation of heparin products, 8-9 July 2010, London, UK. http://www.hpa-events.org.uk/hpa/frontend/reg/tOtherPage.csp?pageID= 50747&eventID=111&eventID=111
15. C Viskov E Bouley P Hubert C Martinez F Herman W Jeske D Hoppensteadt JM Walenga J Fareed 2009 Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin Clin Appl Thromb/Hemost 15 4 395 401 1:CAS:528:DC%2BD1MXhtValu7vE 10.1177/1076029609338710
16. S Tanabe M Hase T Yano M Sato T Fujimura H Akiyama 2007 A real-time quantitative PCR detection method for pork, chicken, beef, mutton, and horseflesh in foods Biosci Biotechnol Biochem 71 12 3131 3135 1:CAS:528:DC%2BD1cXktVKjuw%3D%3D 10.1271/bbb.70683
17. Vydelingum S, Sarcey E, Mallet L (2009) Quantification of residual DNA. In: USP Annual Scientific Meeting Quality of Manufactured Medicines Biologics and Biotechnology and Measurement Science, Toronto, ON, Canada
18. Q Huang CY Yao B Chen F Wang JF Huang X Zhang WL Fu 2006 Species-specific identification by inhibitor-controlled PCR of ruminant components contaminating industrial crude porcine heparin Mol Cell Probes 20 250 258 1:CAS:528:DC%2BD28XksVCrurk%3D 10.1016/j.mcp.2006.01.005
19. LJ Hartmann SR Coyne DA Norwood 2005 Development of a novel internal positive control for Taqman based assays Mol Cell Probes 19 51 59 10.1016/j.mcp.2004.07.006
20. C Tami M Puig JC Reepmeyer H Ye DA D'Avignon L Buhse D Verthelyi 2008 Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants Biomaterials 29 36 4808 4814 1:CAS:528:DC%2BD1cXht1Grt7fM 10.1016/j.biomaterials.2008.08.024